RCUS
Price
$8.77
Change
+$0.16 (+1.86%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
939.2M
70 days until earnings call
SPRY
Price
$14.53
Change
+$0.31 (+2.18%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
1.41B
76 days until earnings call
Interact to see
Advertisement

RCUS vs SPRY

Header iconRCUS vs SPRY Comparison
Open Charts RCUS vs SPRYBanner chart's image
Arcus Biosciences
Price$8.77
Change+$0.16 (+1.86%)
Volume$21.79K
Capitalization939.2M
ARS Pharmaceuticals
Price$14.53
Change+$0.31 (+2.18%)
Volume$18.42K
Capitalization1.41B
RCUS vs SPRY Comparison Chart
Loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCUS vs. SPRY commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a StrongBuy and SPRY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (RCUS: $8.61 vs. SPRY: $14.22)
Brand notoriety: RCUS and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 98% vs. SPRY: 78%
Market capitalization -- RCUS: $939.2M vs. SPRY: $1.41B
RCUS [@Biotechnology] is valued at $939.2M. SPRY’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, SPRY is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 5 TA indicator(s) are bullish while SPRY’s TA Score has 7 bullish TA indicator(s).

  • RCUS’s TA Score: 5 bullish, 3 bearish.
  • SPRY’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than RCUS.

Price Growth

RCUS (@Biotechnology) experienced а +0.82% price change this week, while SPRY (@Biotechnology) price change was +17.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

RCUS is expected to report earnings on Jul 31, 2025.

SPRY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.41B) has a higher market cap than RCUS($939M). SPRY YTD gains are higher at: 34.787 vs. RCUS (-42.176). SPRY has higher annual earnings (EBITDA): -60.51M vs. RCUS (-377M). RCUS has more cash in the bank: 997M vs. SPRY (205M). SPRY has less debt than RCUS: SPRY (102K) vs RCUS (60M). RCUS has higher revenues than SPRY: RCUS (141M) vs SPRY (2.57M).
RCUSSPRYRCUS / SPRY
Capitalization939M1.41B67%
EBITDA-377M-60.51M623%
Gain YTD-42.17634.787-121%
P/E RatioN/A151.25-
Revenue141M2.57M5,491%
Total Cash997M205M486%
Total Debt60M102K58,824%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RCUSSPRY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSCRX14.65N/A
N/A
Putnam Small Cap Value R
TEMGX9.35N/A
N/A
Templeton Global Smaller Comp A
MMCRX17.37N/A
N/A
Madison Mid Cap R6
MGQLX17.10N/A
N/A
Morgan Stanley Inst Global Stars L
MLRTX9.42-0.17
-1.77%
NYLI Winslow Large Cap Growth Class R2

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-0.77%
LPCN - SPRY
63%
Loosely correlated
-0.55%
ANAB - SPRY
36%
Loosely correlated
-1.40%
KRYS - SPRY
35%
Loosely correlated
-3.70%
APGE - SPRY
34%
Loosely correlated
-0.40%
RCUS - SPRY
34%
Loosely correlated
-2.93%
More